ForeverLabs
servicesprovidersmission
Schedule a consultation

Regenerative Medicine Insights

Clinical trials, aesthetic applications, regulatory updates, research studies, and industry insights from the world of regenerative medicine

K

Latest Articles

Active Filters:
Tag: Insulin Like Growth Factor 1 Receptor
generated-image.jpg
Clinical
Dec 1, 2025
1 min read
Pmc
Role of Insulin-like Growth Factor 1 Receptor Signaling in Stem Cell Stemness and Therapeutic Efficacy
New research highlights the critical role of insulin-like growth factor 1 receptor (IGF1R) in enhancing stem cell self-renewal and therapeutic potential. Understanding IGF1R signaling could significantly improve regenerative treatments, making stem cell preservation more valuable for future health needs.
Insulin Like Growth Factor 1 Receptorstem-cell-therapyNeuroprotectionCardiac Regeneration

Stay in touch

Shop

Annual planLifetime PlanClient Login

Learn

ArticlesBlogFAQ

Careers

About usPrivacy PolicyPressTerms of Service

For Clinics

Scheduler LoginFor PhysiciansPartner With UsContact Us
ForeverLabs

Follow Us

FacebookXInstagramLinkedInYouTube

FDA and Stem Cell Therapies

The U.S. Food and Drug Administration (FDA) regulates stem cell therapies as biological products to ensure their safety and efficacy. The FDA requires that stem cell therapies undergo rigorous clinical trials to demonstrate safety and effectiveness before approval. Patients considering stem cell treatments should consult with their healthcare providers about FDA-approved options and be cautious of unproven therapies that have not undergone proper regulatory review.